Skip to content

Bard® InLay Optima® Multilength Ureteral Stent 788800Recalls & reported problems

C. R. Bard, Inc. · INLAY OPTIMA MULTILENGTH URETERAL STENT W/O GUIDEWIRE · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00801741015878), received between Feb 1, 2021 and Feb 1, 2021 — classified as 1 malfunction.

The most frequently reported specific device problem is “Unsealed Device Packaging” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Unsealed Device Packaging1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1
  • No Patient Involvement1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 1, 2021Unsealed Device Packaging; Unsealed Device Packaging

    IT WAS REPORTED THAT THE HOSPITAL STAFF FOUND THAT THE STERILE PACKAGE WAS NOT FULLY SEALED UPON REMOVING FROM THE BOX.

    Patient problems: No Clinical Signs, Symptoms or Conditions; No Patient Involvement

    MAUDE report 11262541 ↗

Other STENT, URETERAL devices

All STENT, URETERAL devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page